Paid Clinical Trials for Colorectal Cancer

Login to your account

Reset Password

Please Enter Username or Email

Create a free account

I'm a Participant
I'm an Organization

Showing 1 – 20 of 103 results

Lead-212 PSV359 Therapy for Patients With Solid Tumors

by CTG

in Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Esophageal Cancer, Pancreatic Ductal Adenocarcinoma

Other

Missouri

Deadline:

05/28/2032

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

by CTG

in Colorectal Cancer, Pancreatic Cancer, Gastric Cancer, Esophageal Cancer, Metastatic Sarcoma

Other

California

Deadline:

04/01/2026

Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)

by CTG

in Colorectal Cancer, Metastatic Colorectal Cancer, Microsatellite Stable Metastatic Colorectal Cancer

Other

Maryland

Deadline:

06/01/2027

IMProving Adherence to Colonoscopy Through Teams and Technology

by CTG

in Colorectal Cancer, Colon Cancer, Cancer Colorectal

Other

California

Deadline:

03/01/2027

ASPirin Intervention for the REDuction of Colorectal Cancer Risk

by CTG

in Colorectal Cancer

Other

Massachusetts

Deadline:

07/01/2029

Preserving Fertility After Colorectal Cancer Study

by CTG

in Colorectal Cancer

Other

Tennessee

Deadline:

12/01/2037

A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

by CTG

in Colorectal Cancer, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-Resistant Prostate Cancer, Renal Cell Carcinoma, Neoplasm Malignant

Other

California

Deadline:

05/31/2027

Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk

by CTG

in Colorectal Cancer

Other

New York

Deadline:

08/31/2026

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

by CTG

in Colorectal Cancer, Colorectal Cancer Stage IV, Stage IV Colorectal Cancer Positive for BRAF V600E Mutation

Other

Illinois

Deadline:

07/01/2028

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

by CTG

in Breast Cancer, Cervical Cancer, Colorectal Cancer, Brain Cancer, Bladder Cancer

Other

California

Deadline:

03/01/2027

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

by CTG

in Colorectal Cancer, Pancreatic Cancer, Gastric Cancer, Locally Advanced or Metastatic Solid Tumors

Other

California

Deadline:

12/01/2030

Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

by CTG

in Breast Cancer, Colorectal Cancer

Other

Alabama

Deadline:

12/31/2026

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

by CTG

in Colorectal Cancer, Colorectal Adenoma, Colorectal Neoplasms, Colorectal Polyp, Digestive System Disease

Other

Alabama

Deadline:

12/31/2035

Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer

by CTG

in Colorectal Carcinoma, Colorectal Cancer, Colorectal Neoplasms

Other

New Jersey

Deadline:

03/18/2026

Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer

by CTG

in Colorectal Cancer, Rectal Cancer

Other

Missouri

Deadline:

12/31/2028

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

by CTG

in Non Small Cell Lung Cancer, Colorectal Cancer, NSCLC, Solid Tumor, Adult, NSCLC, Recurrent

Other

Arizona

Deadline:

06/01/2029

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

by CTG

in Colorectal Cancer, Metastatic Colorectal Adenocarcinoma, Triple Negative Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-)

Other

Michigan

Deadline:

04/14/2030

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

by CTG

in Colorectal Cancer

Other

California

Deadline:

11/01/2029

Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008)

by CTG

in Colorectal Cancer

Other

Florida

Deadline:

06/25/2026

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

by CTG

in Colorectal Cancer, Urothelial Carcinoma, Intrahepatic Cholangiocarcinoma, Squamous Non-small-cell Lung Cancer, Cervical Squamous Cell Carcinoma

Other

California

Deadline:

10/04/2029

Load more All clinical trials loaded.